PRODUCTS

  • > > Systemic Antibacterial

    Prezolid Injection

    English Name ：
    Prezolid Injection
    R&D code ：
    APA-563
    Product Licence  ：
    衛部藥製字第059221號
    NHI. NO. ：
    AC59221266
    Ingredients ：
    Linezolid 2 mg/mL
    Dosage Form ：
    Injection
    Strength ：
    300 mL
    包裝規格 ：
    10 Soft Bag
    Marketing Status ：
    處方用藥
    Controlled Drugs ：
    NO
    Manufacturing Place ：
    Taiwan
    ATC Code ：
    J01XX08
    Indications  ：
    Susceptible vancomycin-resistant E. faecium (VREF) infections, nosocomial and community-acquired pneumonia, complicated skin and skin structure infections (including diabetic foot infections) without osteomyelitis, uncomplicated skin and skin structure infections.
    Dosage ：
    Infuse inj over 30–120 mins; switch to oral form when appropriate. VREF: 600mg every 12hrs for 14–28 days. Pneumonia, complicated skin and skin structure: 600mg every 12hrs for 10–14 days. Uncomplicated skin and skin structure (oral forms only): 12–17yrs: 600mg every 12hrs; >17yrs: 400mg every 12hrs; both for 10–14 days. MRSA: 600mg every 12hrs.
    NHI. Price. ：
    874
    NHI. Effective Date ：
    106.12.01
    Licence Expire Day ：
    110/06/21
    Product Code ：
    41103003U5632
產品資訊查詢：https://lmspiq.fda.gov.tw/web/DRPIQ/DRPIQ1000Result?licId=51059221
More
More Pro. Close Menu TOP